{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2", "antiviral agents", "herbs", "medicinal plants", "phytochemicals"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33809963", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "22"}], "Language": ["eng"], "ELocationID": ["1775", "10.3390/molecules26061775"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "6", "PubDate": {"Year": "2021", "Month": "Mar", "Day": "22"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2.", "Abstract": {"AbstractText": ["The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally. With no specific and effective antiviral therapy for COVID-19, new or repurposed antiviral are urgently needed. Phytochemicals pose a ray of hope for human health during this pandemic, and a great deal of research is concentrated on it. Phytochemicals have been used as antiviral agents against several viruses since they could inhibit several viruses via different mechanisms of direct inhibition either at the viral entry point or the replication stages and via immunomodulation potentials. Recent evidence also suggests that some plants and its components have shown promising antiviral properties against SARS-CoV-2. This review summarizes certain phytochemical agents along with their mode of actions and potential antiviral activities against important viral pathogens. A special focus has been given on medicinal plants and their extracts as well as herbs which have shown promising results to combat SARS-CoV-2 infection and can be useful in treating patients with COVID-19 as alternatives for treatment under phytotherapy approaches during this devastating pandemic situation."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Anand", "ForeName": "Arumugam Vijaya", "Initials": "AV"}, {"Identifier": ["0000-0001-6938-1495"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul 05006, Korea."}], "LastName": "Balamuralikrishnan", "ForeName": "Balasubramanian", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Kaviya", "ForeName": "Mohandass", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Bharathi", "ForeName": "Kathirvel", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Genetics and Epigenetics Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Parithathvi", "ForeName": "Aluru", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Life Sciences, CHRIST (Deemed to be University), Bengaluru 560029, India."}], "LastName": "Arun", "ForeName": "Meyyazhagan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Forest Genetics and Tree Breeding (IFGTB), Forest Campus, Cowley Brown Road, RS Puram, Coimbatore 641002, India."}], "LastName": "Senthilkumar", "ForeName": "Nachiappan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Velayuthaprabhu", "ForeName": "Shanmugam", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Bharathiar University, Coimbatore 641046, India."}], "LastName": "Saradhadevi", "ForeName": "Muthukrishnan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia."}], "LastName": "Al-Dhabi", "ForeName": "Naif Abdullah", "Initials": "NA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Xavier Research Foundation, St. Xavier's College, Palayamkottai, Thirunelveli 627002, India."}], "LastName": "Arasu", "ForeName": "Mariadhas Valan", "Initials": "MV"}, {"Identifier": ["0000-0002-4501-7354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Veterinary Sciences and Animal Husbandry, Sher-E-Kashmir University of Agricultural Sciences and Technology of Kashmir, Shalimar, Srinagar 190006, India."}], "LastName": "Yatoo", "ForeName": "Mohammad Iqbal", "Initials": "MI"}, {"Identifier": ["0000-0001-7763-5547"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura 281001, India."}], "LastName": "Tiwari", "ForeName": "Ruchi", "Initials": "R"}, {"Identifier": ["0000-0001-7469-4752"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly 243122, India."}], "LastName": "Dhama", "ForeName": "Kuldeep", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "India"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "pathogenicity"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "Authors do not have any conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dhama K., Khan S., Tiwari R., Sircar S., Bhat S., Malik Y.S., Singh K.P., Chaicumpa W., Bonilla-Aldana D.K., Rodriguez-Morales A.J. Coronavirus disease 2019-COVID-19. Clin. Microbiol. Rev. 2020;33:e00028-20. doi: 10.1128/CMR.00028-20.", "ArticleIdList": ["10.1128/CMR.00028-20", "PMC7405836", "32580969"]}, {"Citation": "Aanouz I., Belhassan A., El-Khatabi K., Lakhlifi T., El-Ldrissi M., Bouachrine M. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. J. Biomol. Struct. Dyn. 2020:1\u20139. doi: 10.1080/07391102.2020.1758790.", "ArticleIdList": ["10.1080/07391102.2020.1758790", "PMC7212546", "32306860"]}, {"Citation": "Divya M., Vijayakumar S., Chen J., Vaseeharan B., Dur\u00e1n-Lara E.F. A review of South Indian medicinal plant has the ability to combat against deadly viruses along with COVID-19? Microb. Pathog. 2020:104277. doi: 10.1016/j.micpath.2020.104277.", "ArticleIdList": ["10.1016/j.micpath.2020.104277", "PMC7253980", "32473390"]}, {"Citation": "Jahan I., Onay A. Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 2020;44:228\u2013241. doi: 10.3906/biy-2005-114.", "ArticleIdList": ["10.3906/biy-2005-114", "PMC7314514", "32595359"]}, {"Citation": "Ul Qamar M.T., Alqahtani S.M., Alamri M.A., Chen L.L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J. Pharm. Anal. 2020;10:313\u2013319. doi: 10.1016/j.jpha.2020.03.009.", "ArticleIdList": ["10.1016/j.jpha.2020.03.009", "PMC7156227", "32296570"]}, {"Citation": "Xu J., Zhang Y. Traditional Chinese medicine treatment of COVID-19. Complement. Clin. Pr. 2020;39:101165. doi: 10.1016/j.ctcp.2020.101165.", "ArticleIdList": ["10.1016/j.ctcp.2020.101165", "PMC7118627", "32379692"]}, {"Citation": "Devanssh M. Possible plant based medicines and phytochemicals to be cure for deadly coronavirus COVID 19. World J. Pharm. Pharm. Sci. 2020;9:531\u2013533. doi: 10.20959/wjpps20205-16067.", "ArticleIdList": ["10.20959/wjpps20205-16067"]}, {"Citation": "Mani J.S., Johnson J.B., Steel J.C., Broszczak D.A., Neilsen P.M., Walsh K.B., Naiker M. Natural product-derived phytochemicals as potential agents against coronaviruses: A review. Virus Res. 2020;284:197989. doi: 10.1016/j.virusres.2020.197989.", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "Joshi T., Joshi T., Sharma P., Mathpal S., Pundir H., Bhatt V., Chandra S. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur. Rev. Med. Pharm. Sci. 2020;24:4529\u20134536. doi: 10.26355/eurrev_202004_21036.", "ArticleIdList": ["10.26355/eurrev_202004_21036", "32373991"]}, {"Citation": "Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y., Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak\u2013an update on the status. Mil. Med Res. 2020;7:1\u201310. doi: 10.1186/s40779-020-00240-0.", "ArticleIdList": ["10.1186/s40779-020-00240-0", "PMC7068984", "32169119"]}, {"Citation": "Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease. 2015;26:225\u2013236. doi: 10.1007/s13337-015-0276-6.", "ArticleIdList": ["10.1007/s13337-015-0276-6", "PMC4663710", "26645032"]}, {"Citation": "Tiwari R., Latheef S.K., Ahmed I., Iqbal H., Bule M.H., Dhama K., Samad H.A., Karthik K., Alagawany M., El-Hack M.E., et al. Herbal immunomodulators\u2014A remedial panacea for designing and developing effective drugs and medicines: Current scenario and future prospects. Curr. Drug Metab. 2018;19:264\u2013301. doi: 10.2174/1389200219666180129125436.", "ArticleIdList": ["10.2174/1389200219666180129125436", "29380694"]}, {"Citation": "Dhama K., Karthik K., Khandia R., Munjal A., Tiwari R., Rana R., Khurana S.K., Ullah S., Khan R.U., Alagawany M., et al. Medicinal and therapeutic potential of herbs and plant metabolites / extracts countering viral pathogens\u2014Current knowledge and future prospects. Curr. Drug Metab. 2018;19:236\u2013263. doi: 10.2174/1389200219666180129145252.", "ArticleIdList": ["10.2174/1389200219666180129145252", "29380697"]}, {"Citation": "Mousavizadeh L., Ghasemi S. Genotype and phenotype of COVID-19: Their roles in pathogenesis. J. Microbiol. Immunol. Infect. 2020:S1684-1182(20)30082-7. doi: 10.1016/j.jmii.2020.03.022.", "ArticleIdList": ["10.1016/j.jmii.2020.03.022", "PMC7138183", "32265180"]}, {"Citation": "De Haan C.A., Kuo L., Masters P.S., Vennema H., Rottier P.J. Coronavirus particle assembly: Primary structure requirements of the membrane protein. J. Virol. 1998;72:6838\u20136850. doi: 10.1128/JVI.72.8.6838-6850.1998.", "ArticleIdList": ["10.1128/JVI.72.8.6838-6850.1998", "PMC109893", "9658133"]}, {"Citation": "van Boheemen S., de Graaf M., Lauber C., Bestebroer T.M., Raj V.S., Zaki A.M., Osterhaus A.D., Haagmans B.L., Gorbalenya A.E., Snijder E.J., et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio. 2012;3:e00473-12. doi: 10.1128/mBio.00473-12.", "ArticleIdList": ["10.1128/mBio.00473-12", "PMC3509437", "23170002"]}, {"Citation": "Czub M., Weingartl H., Czub S., He R., Cao J. Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine. 2005;23:2273\u20132279. doi: 10.1016/j.vaccine.2005.01.033.", "ArticleIdList": ["10.1016/j.vaccine.2005.01.033", "PMC7115540", "15755610"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Schroeder S., Kr\u00fcger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271\u2013280.e8. doi: 10.1016/j.cell.2020.02.052.", "ArticleIdList": ["10.1016/j.cell.2020.02.052", "PMC7102627", "32142651"]}, {"Citation": "South A.M., Brady T.M., Flynn J.T. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) receptor blocker use during the pandemic: The pediatric perspective. Hypertension. 2020;76:16\u201322. doi: 10.1161/HYPERTENSIONAHA.120.15291.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.120.15291", "PMC7289676", "32367746"]}, {"Citation": "Sola I., Almazan F., Zuniga S., Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annu. Rev. Virol. 2015;2:265\u2013288. doi: 10.1146/annurev-virology-100114-055218.", "ArticleIdList": ["10.1146/annurev-virology-100114-055218", "PMC6025776", "26958916"]}, {"Citation": "Ziebuhr J. Coronavirus replication and reverse genetics. In: Enjuanes L., editor. Current Topics in Microbiology and Immunology. Volume 287. Springer; Berlin/Heidelberg, Germany: 2005. pp. 57\u201394.", "ArticleIdList": ["10.1007/3-540-26765-4_3", "0"]}, {"Citation": "\u0160ebera J., Dubankova A., Sychrovsk\u00fd V., Ruzek D., Boura E., Nencka R. The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors. Sci. Rep. 2018;8:11132. doi: 10.1038/s41598-018-29459-7.", "ArticleIdList": ["10.1038/s41598-018-29459-7", "PMC6057956", "30042483"]}, {"Citation": "Rupprecht C.E. Medical Microbiology. 4th ed. University of Texas Medical Branch at Galveston; Galveston, TX, USA: 1996. Rhabdovirus."}, {"Citation": "Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., et al. Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion. Cell. 2002;108:717\u2013725. doi: 10.1016/S0092-8674(02)00660-8.", "ArticleIdList": ["10.1016/S0092-8674(02)00660-8", "PMC4152842", "11893341"]}, {"Citation": "Jilani T.N., Jamil R.T., Siddiqui A.H. StatPearls. Stat Pearls Publishing; Treasure Island, FL, USA: 2019. H1N1 influenza (swine flu)"}, {"Citation": "Ganesan V.K., Duan B., Reid S.P. Chikungunya virus: Pathophysiology, mechanism, and modeling. Viruses. 2017;9:368. doi: 10.3390/v9120368.", "ArticleIdList": ["10.3390/v9120368", "PMC5744143", "29194359"]}, {"Citation": "Lee J.E., Saphire E.O. Ebolavirus glycoprotein structure and mechanism of entry. Future Virol. 2009;4:621\u2013635. doi: 10.2217/fvl.09.56.", "ArticleIdList": ["10.2217/fvl.09.56", "PMC2829775", "20198110"]}, {"Citation": "Bafna K., Krug R.M., Montelione G.T. Structural similarity of SARS-CoV-2 Mpro and HCV NS3/4A proteases suggests new approaches for identifying existing drugs useful as COVID-19 therapeutics. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12153615.", "ArticleIdList": ["10.26434/chemrxiv.12153615"]}, {"Citation": "Biswas A., Bhattacharjee U., Chakrabarti A.K., Tewari D.N., Banu H., Dutta S. Emergence of novel coronavirus and COVID-19: Whether to stay or die out? Crit. Rev. Microbiol. 2020;46:182\u2013193. doi: 10.1080/1040841X.2020.1739001.", "ArticleIdList": ["10.1080/1040841X.2020.1739001", "PMC7157960", "32282268"]}, {"Citation": "Fanales-Belasio E., Raimondo M., Suligoi B., Butt\u00f2 S. HIV virology and pathogenetic mechanisms of infection: A brief overview. Ann. Sanita. 2010;46:5\u201314. doi: 10.1590/S0021-25712010000100002.", "ArticleIdList": ["10.1590/S0021-25712010000100002", "20348614"]}, {"Citation": "Gupta H.M., Gupta S., Bhargava S. Potential use of Turmeric in COVID-19. Clin. Exp. Derm. 2020 doi: 10.1111/ced.14357.", "ArticleIdList": ["10.1111/ced.14357", "PMC7361299", "32608046"]}, {"Citation": "Li Y., Liu X., Guo L., Li J., Zhong D., Zhang Y., Clarke M., Jin R. Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: Protocol for a systematic review and meta-analysis. Syst. Rev. 2020;9:75. doi: 10.1186/s13643-020-01343-4.", "ArticleIdList": ["10.1186/s13643-020-01343-4", "PMC7138957", "32268923"]}, {"Citation": "Junhai J. Inventor Herbal Medicine for Treating and Preventing Rabies, Herbal Medicine for Treating and Preventing Rabies. No. CN 200510032451. Patent. 2005 Nov 23;"}, {"Citation": "Bliah M.A.M. Google Patents. Antiviral Composition. No. EP19850109500. Patent. 1987 Aug 19;"}, {"Citation": "Chandan B.K., Sharma A.K., Anand K.K. Boerhaavia diffusa: A study of its hepatoprotective activity. J. Ethnopharmacol. 1991;31:299\u2013307. doi: 10.1016/0378-8741(91)90015-6.", "ArticleIdList": ["10.1016/0378-8741(91)90015-6", "2056758"]}, {"Citation": "Verma H.N., Awasthi L.P. Occurrence of a highly antiviral agent in plants treated with Boerhaavia diffusa inhibitor. Can. J. Bot. 1980;58:2141\u20132144. doi: 10.1139/b80-246.", "ArticleIdList": ["10.1139/b80-246"]}, {"Citation": "Dalal S., Kataria S.K., Sastry K.V., Rana S.V. Phytochemical screening of methanolic extract and antibacterial activity of active principles of hepatoprotective herb, Eclipta alba.  [(accessed on 21 July 2020)];Ethnobot. Leafl. 2010 2010:3. Available online:  https://opensiuc.lib.siu.edu/ebl/vol2010/iss3/3."}, {"Citation": "Anbazhagan G.K., Palaniyandi S., Joseph B. Plant Extracts. Intech Open Dekebo, A; London, UK: 2019. Antiviral Plant Extracts.", "ArticleIdList": ["10.5772/intechopen.85126"]}, {"Citation": "Razdan R., Dev M.A. Preventive and curative effects of Vedic Guard against antitubercular drugs induced hepatic damage in rats. Pharmacogn. Mag. 2008;4:182\u2013188."}, {"Citation": "Mukherjee P.K. Antiviral evaluation of herbal drugs. Qual. Control. Eval. Herb. Drugs. 2019:599\u2013628. doi: 10.1016/B978-0-12-813374-3.00016-8.", "ArticleIdList": ["10.1016/B978-0-12-813374-3.00016-8"]}, {"Citation": "McGill M.R., Du K., Weemhoff J.L., Jaeschke H. Critical review of resveratrol in xenobiotic-induced hepatotoxicity. Food Chem. Toxicol. 2015;86:309\u2013318. doi: 10.1016/j.fct.2015.11.003.", "ArticleIdList": ["10.1016/j.fct.2015.11.003", "PMC4710062", "26561740"]}, {"Citation": "Cortegiani A., Ingoglia G., Ippolito M., Giarratano A., Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J. Crit. Care. 2020;57:279\u2013283. doi: 10.1016/j.jcrc.2020.03.005.", "ArticleIdList": ["10.1016/j.jcrc.2020.03.005", "PMC7270792", "32173110"]}, {"Citation": "Li X., Wang Y., Agostinis P., Rabson A., Melino G., Carafoli E., Shi Y., Sun E. Is hydroxychloroquine beneficial for COVID-19 patients? Cell Death Dis. 2020;11:1\u20136.", "ArticleIdList": ["PMC7341710", "32641681"]}, {"Citation": "Singh A.K., Singh A., Shaikh A., Singh R., Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab. Syndr. 2020;14:241\u2013246. doi: 10.1016/j.dsx.2020.03.011.", "ArticleIdList": ["10.1016/j.dsx.2020.03.011", "PMC7102587", "32247211"]}, {"Citation": "Salehi B., Shivaprasad Shetty M., V Anil Kumar N., \u017divkovi\u0107 J., Calina D., Oana Docea A., Emamzadeh-Yazdi S., Sibel K\u0131l\u0131\u00e7 C., Goloshvili T., Nicola S., et al. Veronica plants-drifting from farm to traditional healing, food application, and phytopharmacology. Molecules. 2019;24:2454. doi: 10.3390/molecules24132454.", "ArticleIdList": ["10.3390/molecules24132454", "PMC6651156", "31277407"]}, {"Citation": "Malik K., Ahmad M., Zafar M., Ullah R., Mahmood H.M., Parveen B., Rashid N., Sultana S., Shah S.N. An ethnobotanical study of medicinal plants used to treat skin diseases in northern Pakistan. BMC Complementary Altern. Med. 2019;19:210. doi: 10.1186/s12906-019-2605-6.", "ArticleIdList": ["10.1186/s12906-019-2605-6", "PMC6693210", "31409400"]}, {"Citation": "Chattopadhyay D., Ojha D., Mondal S., Goswami D. Validation of antiviral potential of herbal ethnomedicine. In: Mukherjee P.K., editor. Evidence-Based Validation of Herbal Medicine. Elsevier; Amsterdam, The Netherlands: 2015. pp. 175\u2013200.", "ArticleIdList": ["10.1016/B978-0-12-800874-4.00008-8"]}, {"Citation": "Chandra S., Rawat D.S. Medicinal plants of the family Caryophyllaceae: A review of ethno-medicinal uses and pharmacological properties. Integr. Med. Res. 2015;4:123\u2013131. doi: 10.1016/j.imr.2015.06.004.", "ArticleIdList": ["10.1016/j.imr.2015.06.004", "PMC5481791", "28664118"]}, {"Citation": "Umesh K.D., Selvaraj C., Singh S.K., Dubey V.K. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. J. Biomol. Struct. Dyn. 2020:1\u20139. doi: 10.1080/07391102.2020.1763202.", "ArticleIdList": ["10.1080/07391102.2020.1763202", "PMC7232883", "32362243"]}, {"Citation": "Sarma P., Shekhar N., Prajapat M. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) J. Biomol. Struct. Dyn. 2020:1\u20139. doi: 10.1080/07391102.2020.1753580.", "ArticleIdList": ["10.1080/07391102.2020.1753580", "PMC7256351", "32266867"]}, {"Citation": "Gupta M.K., Vemula S., Donde R., Gouda G., Behera L., Vadde R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J. Biomol. Struct. Dyn. 2020:1\u201311. doi: 10.1080/07391102.2020.1751300.", "ArticleIdList": ["10.1080/07391102.2020.1751300", "PMC7171389", "32238078"]}, {"Citation": "Sinha S.K., Prasad S.K., Islam M.A., Gurav S.S., Patil R.B., AlFaris N.A., Aldayel T.S., AlKehayez N.M., Wabaidur S.M., Shakya A. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: A pharmacoinformatics study. J. Biomol. Struct. Dyn. 2020:1\u201315. doi: 10.1080/07391102.2020.1779132.", "ArticleIdList": ["10.1080/07391102.2020.1779132", "PMC7309308", "32552462"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Michaelis M., Geiler J., Naczk P., Sithisarn P., Leutz A., Doerr H.W., Cinatl J., Jr. Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS ONE. 2011;6:e19705. doi: 10.1371/journal.pone.0019705.", "ArticleIdList": ["10.1371/journal.pone.0019705", "PMC3096629", "21611183"]}, {"Citation": "Murck H. Symptomatic Protective action of glycyrrhizin (licorice) in COVID-19 Infection? Front. Immunol. 2020;11:1239. doi: 10.3389/fimmu.2020.01239.", "ArticleIdList": ["10.3389/fimmu.2020.01239", "PMC7270278", "32574273"]}, {"Citation": "LuoLiu P., Li J. Pharmacologic perspective: Glycyrrhizin may be an efficacious therapeutic agent for COVID-19. Int J. Antimicrob. Agents. 2020:105995. doi: 10.1016/j.ijantimicag.2020.105995.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105995", "PMC7180159", "32335281"]}, {"Citation": "Bailly C., Vergoten G. Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Pharmacol. Ther. 2020;214:107618. doi: 10.1016/j.pharmthera.2020.107618.", "ArticleIdList": ["10.1016/j.pharmthera.2020.107618", "PMC7311916", "32592716"]}, {"Citation": "Subramanian S. Some FDA Approved drugs exhibit binding affinity as high as-16.0 kcal/mol against COVID-19 Main Protease (Mpro): A molecular docking study. IndiaRxiv. 2020:1\u20136. doi: 10.35543/osf.io/t7jsd.", "ArticleIdList": ["10.35543/osf.io/t7jsd"]}, {"Citation": "Joshi G., Sharma S., Acharya J., Parida M. Assessment of In vitro antiviral activity of Ocimum sanctum (Tulsi) against pandemic swine flu H1N1 virus infection. World Res. J. Antimicrob. Agents. 2014;3:062\u2013067."}, {"Citation": "Mohapatra P.K., Chopdar K.S., Dash G.C., Raval M.K. In silico screening of phytochemicals of Ocimum sanctum against main protease of SARS-CoV-2. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12599915.v1.", "ArticleIdList": ["10.26434/chemrxiv.12599915.v1", "34821198"]}, {"Citation": "Purthvish R., Gopinatha S.M. Antiviral prospective of Tinospora cordifolia on HSV-1. Int. J. Curr. Microbiol. App. Sci. 2018;7:3617\u20133624. doi: 10.20546/ijcmas.2018.701.425.", "ArticleIdList": ["10.20546/ijcmas.2018.701.425"]}, {"Citation": "Krupanidhi S., Abraham P.K., Venkateswarulu T.C., Ayyagari V.S., Nazneen Bobby M., John Babu D., Venkata Narayana A., Aishwarya G. Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: An in silico study. J. Biomol. Struct. Dyn. 2020:1\u20135. doi: 10.1080/07391102.2020.1787226.", "ArticleIdList": ["10.1080/07391102.2020.1787226", "PMC7441789", "32627715"]}, {"Citation": "Donma M.M., Donma O. The effects of Allium sativum on immunity within the scope of COVID-19 infection. Med. Hypotheses. 2020;144:109934. doi: 10.1016/j.mehy.2020.109934.", "ArticleIdList": ["10.1016/j.mehy.2020.109934", "PMC7265825", "32512493"]}, {"Citation": "Thuy B.T.P., My T.T.A., Hai N.T.T., Hieu L.T., Hoa T.T., Thi Phuong Loan H., Triet N.T., Anh T.T.V., Quy P.T., Tat P.V., et al. Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega. 2020;5:8312\u20138320. doi: 10.1021/acsomega.0c00772.", "ArticleIdList": ["10.1021/acsomega.0c00772", "PMC7123907", "32363255"]}, {"Citation": "Wintachai P., Kaur P., Lee R.C., Ramphan S., Kuadkitkan A., Wikan N., Ubol S., Roytrakul S., Chu J.J., Smith D.R. Activity of andrographolide against chikungunya virus infection. Sci. Rep. 2015;5:14179. doi: 10.1038/srep14179.", "ArticleIdList": ["10.1038/srep14179", "PMC4585663", "26384169"]}, {"Citation": "Murugan N.A., Pandian C.J., Jeyakanthan J. Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1777901.", "ArticleIdList": ["10.1080/07391102.2020.1777901", "PMC7309306", "32543978"]}, {"Citation": "Enmozhi S.K., Raja K., Sebastine I., Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. J. Biomol. Struct. Dyn. 2020:1\u20137. doi: 10.1080/07391102.2020.1760136.", "ArticleIdList": ["10.1080/07391102.2020.1760136", "PMC7212536", "32329419"]}, {"Citation": "John J. Therapeutic potential of Withania somnifera: A report on phyto-pharmacological properties. Int J. Pharm Sci Res. 2014;5:2131\u20132148. doi: 10.13040/IJPSR.0975-8232.", "ArticleIdList": ["10.13040/IJPSR.0975-8232"]}, {"Citation": "Kaur N., Junaid N., Raman B. A review on pharmacological profile of Withania somnifera (Ashwagandha) Res. Rev. J. Bot. Sci. 2013;2:6\u201314."}, {"Citation": "Saiyed A., Jahan N., Majeedi S.F., Roqaiya M. Medicinal properties, phytochemistry and pharmacology of Withania somnifera: An important drug of Unani medicine. J. Sci. Innov. Res. 2016;5:156\u2013160."}, {"Citation": "Grover A., Agrawal V., Shandilya A., Bisaria V.S., Sundar D. Non-nucleosidic inhibition of Herpes simplex virus DNA polymerase: Mechanistic insights into the anti-herpetic mode of action of herbal drug withaferin A. BMC Bioinform. 2011;12:1\u20139. doi: 10.1186/1471-2105-12-S13-S22.", "ArticleIdList": ["10.1186/1471-2105-12-S13-S22", "PMC3278839", "22373101"]}, {"Citation": "Tripathi M.K., Singh P., Sharma S., Singh T.P., Ethayathulla A.S., Kaur P. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. J. Biomol. Struct. Dyn. 2020:1\u201314. doi: 10.1080/07391102.2020.1790425.", "ArticleIdList": ["10.1080/07391102.2020.1790425", "PMC7441797", "32643552"]}, {"Citation": "Chikhale R.V., Gurav S.S., Patil R.B., Sinha S.K., Prasad S.K., Shakya A., Shrivastava S.K., Gurav N.S., Prasad R.S. Sars-cov-2 host entry and replication inhibitors from Indian ginseng: An in-silico approach. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1778539.", "ArticleIdList": ["10.1080/07391102.2020.1778539", "PMC7332873", "32568012"]}, {"Citation": "Ichsyani M., Ridhanya A., Risanti M., Desti H., Ceria R., Putri D.H., Sudiro T.M., Dewi B.E. Antiviral effects of Curcuma longa L. against dengue virus in vitro and in vivo. Iniop. Conf. Ser. Earth Environ. Sci. 2017;101:012005. doi: 10.1088/1755-1315/101/1/012005.", "ArticleIdList": ["10.1088/1755-1315/101/1/012005"]}, {"Citation": "Zandi K., Ramedani E., Mohammadi K., Tajbakhsh S., Deilami I., Rastian Z., Fouladvand M., Yousefi F., Farshadpour F. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in Vero cell line. Nat. Prod. Commun. 2010;5:1935\u20131938. doi: 10.1177/1934578X1000501220.", "ArticleIdList": ["10.1177/1934578X1000501220", "21299124"]}, {"Citation": "Gupta S., Singh A.K., Kushwaha P.P., Prajapati K.S., Shuaib M., Senapati S., Kumar S. Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1776157.", "ArticleIdList": ["10.1080/07391102.2020.1776157", "PMC7312383", "32476576"]}, {"Citation": "Ghosh R., Chakraborty A., Biswas A., Chowdhuri S. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors\u2014An in silico docking and molecular dynamics simulation study. J. Biomol. Struct. Dyn. 2020:1\u201313. doi: 10.1080/07391102.2020.1779818.", "ArticleIdList": ["10.1080/07391102.2020.1779818", "PMC7332865", "32568613"]}, {"Citation": "Hamza M., Ali A., Khan S., Ahmed S., Attique Z., Ur Rehman S., Khan A., Ali H., Rizwan M., Munir A., et al. nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine. J. Biomol. Struct. Dyn. 2020:1\u201311. doi: 10.1080/07391102.2020.1778534.", "ArticleIdList": ["10.1080/07391102.2020.1778534", "PMC7332867", "32567487"]}, {"Citation": "Tan W., Jaganath I., Manikam I. Evaluation of antiviral activities of four local Malaysian Phyllanthus species against Herpes simplex viruses and possible antiviral target. Int. J. Med Sci. 2013;10:1817\u20131892. doi: 10.7150/ijms.6902.", "ArticleIdList": ["10.7150/ijms.6902", "PMC3856372", "24324358"]}, {"Citation": "Alzohairy A.M. Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evid. Based Complementary Altern. Med. 2016:7382506. doi: 10.1155/2016/7382506.", "ArticleIdList": ["10.1155/2016/7382506", "PMC4791507", "27034694"]}, {"Citation": "Rao V.B., Yeturu K. Possible Anti-viral effects of Neem (Azadirachta indica) on dengue virus. bioRxiv. 2020 doi: 10.1101/2020.04.29.069567.", "ArticleIdList": ["10.1101/2020.04.29.069567"]}, {"Citation": "Fesseha H., Goa E. Therapeutic value of garlic (Allium sativum): A review. Adv. Food Technol Nutr Sci Open J. 2019;5:107\u2013117. doi: 10.17140/AFTNSOJ-5-162.", "ArticleIdList": ["10.17140/AFTNSOJ-5-162"]}, {"Citation": "Singh S.S., Pandey S.C., Srivastava S., Gupta V.S., Patro B., Ghosh A.C. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi) Indian J. Pharmacol. 2003;35:83\u201391."}, {"Citation": "Paikra B.K., Dhongade H.K.J., Gidwani B. Phytochemistry and pharmacology of Moringa oleifera Lam. J. Pharm. 2017;20:194\u2013200. doi: 10.3831/KPI.2017.20.022.", "ArticleIdList": ["10.3831/KPI.2017.20.022", "PMC5633671", "30087795"]}, {"Citation": "Karmakar P., Pujol C.A., Damonte E.B., Ghosh T., Ray B. Polysaccharides from Padina tetrastromatica: Structural features, chemical modification and antiviral activity. Carbohydr. Polym. 2010;80:513\u2013520. doi: 10.1016/j.carbpol.2009.12.014.", "ArticleIdList": ["10.1016/j.carbpol.2009.12.014"]}, {"Citation": "Herold B.C., Gerber S.I., Polonsky T., Belval B.J., Shaklee P.N., Holme K. Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding. Virology. 1995;206:1108\u20131116. doi: 10.1006/viro.1995.1034.", "ArticleIdList": ["10.1006/viro.1995.1034", "7856085"]}, {"Citation": "Huheihel M., Ishanu V., Tal J. Activity of Porphyridium sp. polysaccharide against herpes simplex viruses in vitro and in vivo. J. Biochem. Biophys. Methods. 2002;50:189\u2013200. doi: 10.1016/S0165-022X(01)00186-5.", "ArticleIdList": ["10.1016/S0165-022X(01)00186-5", "11741707"]}, {"Citation": "Ogbole O.O., Akinleye T.E., Segun P.A., Faleye T.C., Adeniji A.J. In vitro antiviral activity of twenty-seven medicinal plant extracts from Southwest Nigeria against three serotypes of echoviruses. Virol. J. 2018;15:110. doi: 10.1186/s12985-018-1022-7.", "ArticleIdList": ["10.1186/s12985-018-1022-7", "PMC6052623", "30021589"]}, {"Citation": "Andres A., Donovan S.M., Kuhlenschmidt M.S. Soy isoflavones and virus infections. J. Nutr. Biochem. 2009;20:563\u2013569. doi: 10.1016/j.jnutbio.2009.04.004.", "ArticleIdList": ["10.1016/j.jnutbio.2009.04.004", "PMC7125569", "19596314"]}, {"Citation": "Liu A.L., Liu B., Qin H.L., Lee S.M., Wang Y.T., Du G.H. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008;74:847\u2013851. doi: 10.1055/s-2008-1074558.", "ArticleIdList": ["10.1055/s-2008-1074558", "18553272"]}, {"Citation": "Ngwa W., Kumar R., Thompson D., Lyerly W., Moore R., Reid T.E., Lowe H., Toyang N. Potential of flavonoid-inspired phytomedicines against COVID-19. Molecules. 2020;25:2707. doi: 10.3390/molecules25112707.", "ArticleIdList": ["10.3390/molecules25112707", "PMC7321405", "32545268"]}, {"Citation": "Bhowmik D., Nandi R., Kumar D. Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis. ChemRxiv. 2020 doi: 10.26434/chemrxiv.12071508.v1.", "ArticleIdList": ["10.26434/chemrxiv.12071508.v1", "PMC7955945", "33748510"]}, {"Citation": "Colunga Biancatelli R.M.L., Berrill M., Catravas J.D., Marik P.E. Quercetin and vitamin C: An experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19) Front. Immunol. 2020;11:1451. doi: 10.3389/fimmu.2020.01451.", "ArticleIdList": ["10.3389/fimmu.2020.01451", "PMC7318306", "32636851"]}, {"Citation": "Saeed M., Naveed M., Arif M., Kakar M.U., Manzoor R., Abd El-Hack M.E., Alagawany M., Tiwari R., Khandia R., Munjal A., et al. Green tea (Camellia sinensis) and l-theanine: Medicinal values and beneficial applications in humans-A comprehensive review. Biomed. Pharm. 2017;95:1260\u20131275. doi: 10.1016/j.biopha.2017.09.024.", "ArticleIdList": ["10.1016/j.biopha.2017.09.024", "28938517"]}, {"Citation": "Song J.M., Lee K.H., Seong B.L. Antiviral effect of catechins in green tea on influenza virus. Antivir. Res. 2005;68:66\u201374. doi: 10.1016/j.antiviral.2005.06.010.", "ArticleIdList": ["10.1016/j.antiviral.2005.06.010", "16137775"]}, {"Citation": "Isaacs C.E., Wen G.Y., Xu W., Jia J.H., Rohan L., Corbo C., Di Maggio V., Jenkins E.C., Hillier S. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob. Agents Chemother. 2008;52:962\u2013970. doi: 10.1128/AAC.00825-07.", "ArticleIdList": ["10.1128/AAC.00825-07", "PMC2258520", "18195068"]}, {"Citation": "Jena A.B., Kanungo N., Nayak V., Chainy G.B.N., Dandapat J. Catechin and curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane: Insights from computational study and implication for intervention. Nature. 2020 doi: 10.21203/rs.3.rs-22057/v1.", "ArticleIdList": ["10.21203/rs.3.rs-22057/v1", "0"]}, {"Citation": "Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., Lines T.C. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem. Toxicol. 2007;45:2179\u20132205. doi: 10.1016/j.fct.2007.05.015.", "ArticleIdList": ["10.1016/j.fct.2007.05.015", "17698276"]}, {"Citation": "Gonzalez O., Fontanes V., Raychaudhuri S., Loo R., Loo J., Arumugaswami V., Sun R., Dasgupta A., French S.W. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology. 2009;50:1756\u20131764. doi: 10.1002/hep.23232.", "ArticleIdList": ["10.1002/hep.23232", "PMC3846025", "19839005"]}, {"Citation": "Bachmetov L., Gal-Tanamy M., Shapira A., Vorobeychik M., Giterman-Galam T., Sathiyamoorthy P., Golan-Goldhirsh A., Benhar I., Tur-Kaspa R., Zemel R. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J. Viral Hepat. 2012;19:e81\u2013e88. doi: 10.1111/j.1365-2893.2011.01507.x.", "ArticleIdList": ["10.1111/j.1365-2893.2011.01507.x", "22239530"]}, {"Citation": "Ganesan S., Faris A.N., Comstock A.T., Wang Q., Nanua S., Hershenson M.B., Sajjan U.S. Quercetin inhibits rhinovirus replication in vitro and in vivo. Antivir. Res. 2012;94:258\u2013271. doi: 10.1016/j.antiviral.2012.03.005.", "ArticleIdList": ["10.1016/j.antiviral.2012.03.005", "PMC3360794", "22465313"]}, {"Citation": "Zandi K., Teoh B.T., Sam S.S., Wong P.F., Mustafa M.R., Abu Bakar S. Antiviral activity of four types of bioflavonoid against dengue virus type-2. Virol. J. 2011;8:1. doi: 10.1186/1743-422X-8-560.", "ArticleIdList": ["10.1186/1743-422X-8-560", "PMC3271998", "22201648"]}, {"Citation": "Hakobyan A., Arabyan E., Avetisyan A., Abroyan L., Hakobyan L., Zakaryan H. Apigenin inhibits African swine fever virus infection in vitro. Arch. Virol. 2016;161:3445\u20133453. doi: 10.1007/s00705-016-3061-y.", "ArticleIdList": ["10.1007/s00705-016-3061-y", "27638776"]}, {"Citation": "Lv X., Qiu M., Chen D., Zheng N., Jin Y., Wu Z. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway. Antivir. Res. 2014;109:30\u201341. doi: 10.1016/j.antiviral.2014.06.004.", "ArticleIdList": ["10.1016/j.antiviral.2014.06.004", "24971492"]}, {"Citation": "Rogerio A.P., Dora C.L., Andrade E.L., Chaves J.S., Silva L.F., Lemos-Senna E., Calixto J.B. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol. Res. 2010;1:288\u2013297. doi: 10.1016/j.phrs.2009.10.005.", "ArticleIdList": ["10.1016/j.phrs.2009.10.005", "19892018"]}, {"Citation": "Zhang W., Qiao H., Lv Y., Wang J., Chen X., Hou Y., Tan R., Li E. Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-acting factors. PLoS ONE. 2014;9:e110429. doi: 10.1371/journal.pone.0110429.", "ArticleIdList": ["10.1371/journal.pone.0110429", "PMC4199717", "25330384"]}, {"Citation": "Shibata C., Ohno M., Otsuka M., Kishikawa T., Goto K., Muroyama R., Kato N., Yoshikawa T., Takata A., Koike K. The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels. Virology. 2014;462:42\u201348. doi: 10.1016/j.virol.2014.05.024.", "ArticleIdList": ["10.1016/j.virol.2014.05.024", "25092460"]}, {"Citation": "Huang H., Zhou W., Zhu H., Zhou P., Shi X. Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs. Toxicol. Appl. Pharm. 2017;323:36\u201343. doi: 10.1016/j.taap.2017.03.016.", "ArticleIdList": ["10.1016/j.taap.2017.03.016", "28322895"]}, {"Citation": "Sithisarn P., Michaelis M., Schubert-Zsilavecz M., Cinatl Jr J. Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells. Antivir. Res. 2013;97:41\u201348. doi: 10.1016/j.antiviral.2012.10.004.", "ArticleIdList": ["10.1016/j.antiviral.2012.10.004", "23098745"]}, {"Citation": "Xu G., Dou J., Zhang L., Guo Q., Zhou C. Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum. Biol. Pharm. Bull. 2010;33:238\u2013243. doi: 10.1248/bpb.33.238.", "ArticleIdList": ["10.1248/bpb.33.238", "20118546"]}, {"Citation": "Dou J., Chen L., Xu G., Zhang L., Zhou H., Wang H., Su Z., Ke M., Guo Q., Zhou C. Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase. Arch. Virol. 2011;156:793\u2013801. doi: 10.1007/s00705-011-0917-z.", "ArticleIdList": ["10.1007/s00705-011-0917-z", "21286764"]}, {"Citation": "Chu M., Xu L., Zhang M.B., Chu Z.Y., Wang Y.D. Role of Baicalin in anti-influenza virusA as a potent inducer of IFN gamma. Biomed. Res. Int. 2015;2015:263630. doi: 10.1155/2015/263630.", "ArticleIdList": ["10.1155/2015/263630", "PMC4689896", "26783516"]}, {"Citation": "Fan W., Qian S., Qian P., Li X. Antiviral activity of luteolin against Japanese encephalitis virus. Virus Res. 2016;220:112\u2013116. doi: 10.1016/j.virusres.2016.04.021.", "ArticleIdList": ["10.1016/j.virusres.2016.04.021", "27126774"]}, {"Citation": "Knipping K., Garssen J., van\u2019t L.B. An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol. J. 2012;9:1\u20138. doi: 10.1186/1743-422X-9-137.", "ArticleIdList": ["10.1186/1743-422X-9-137", "PMC3439294", "22834653"]}, {"Citation": "Murali K.S., Sivasubramanian S., Vincent S., Murugan S.B., Giridaran B., Dinesh S., Gunasekaran P., Krishnasamy K., Sathishkumar R. Anti-chikungunya activity of luteolin and apigenin rich fraction from Cynodon dactylon. Asian Pac. J. Trop. Med. 2015;8:352\u2013358. doi: 10.1016/S1995-7645(14)60343-6.", "ArticleIdList": ["10.1016/S1995-7645(14)60343-6", "26003593"]}, {"Citation": "Yi L., Li Z., Yuan K., Qu X., Chen J., Wang G., Zhang H., Luo H., Zhu L., Jiang P., et al. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J. Virol. 2004;78:11334\u201311339. doi: 10.1128/JVI.78.20.11334-11339.2004.", "ArticleIdList": ["10.1128/JVI.78.20.11334-11339.2004", "PMC521800", "15452254"]}, {"Citation": "Mehla R., Bivalkar-Mehla S., Chauhan A. Aflavonoid, luteolin, cripples HIV-1 by abrogation of tat function. PLoS ONE. 2011;6:e27915. doi: 10.1371/journal.pone.0027915.", "ArticleIdList": ["10.1371/journal.pone.0027915", "PMC3227592", "22140483"]}, {"Citation": "Wu H., Myszka D.G., Tendian S.W., Brouillette C.G., Sweet R.W., Chaiken I.M., Hendrickson W.A. Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. Proc. Natl. Acad. Sci. USA. 1996;93:15030\u201315035. doi: 10.1073/pnas.93.26.15030.", "ArticleIdList": ["10.1073/pnas.93.26.15030", "PMC26350", "8986758"]}, {"Citation": "Xu L., Su W., Jin J., Chen J., Li X., Zhang X., Sun M., Sun S., Fan P., An D., et al. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses. 2014;6:2778\u20132795. doi: 10.3390/v6072778.", "ArticleIdList": ["10.3390/v6072778", "PMC4113793", "25036464"]}, {"Citation": "Ansari W.A., Ahamad T., Khan M.A., Khan Z.A., Khan M.F. Luteolin: A dietary molecule as potential anti-COVID-19 agent. Comput. Chem. 2020 Jun 16; doi: 10.21203/rs.3.rs-35368/v1.", "ArticleIdList": ["10.21203/rs.3.rs-35368/v1"]}, {"Citation": "Mitrocotsa D., Mitaku S., Axarlis S., Harvala C., Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med. 2000;66:377\u2013379. doi: 10.1055/s-2000-8550.", "ArticleIdList": ["10.1055/s-2000-8550", "10865462"]}, {"Citation": "Schwarz S., Sauter D., Wang K., Zhang R., Sun B., Karioti A., Bilia A.R., Efferth T., Schwarz W. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. 2014;80:177\u2013182. doi: 10.1055/s-0033-1360277.", "ArticleIdList": ["10.1055/s-0033-1360277", "PMC7171712", "24458263"]}, {"Citation": "Yang L., Lin J., Zhou B., Liu Y., Zhu B. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3serine protease. Nat. Prod. Res. 2016;13:1\u20135. doi: 10.1080/14786419.2016.1190719.", "ArticleIdList": ["10.1080/14786419.2016.1190719", "27295355"]}, {"Citation": "Jeong H.J., Ryu Y.B., Park S., Kim J.H., Kwon H.-J., Kim J.H., Park K.H., Rho M.-C., Lee W.S. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg. Med. Chem. 2009;17:6816\u20136823. doi: 10.1016/j.bmc.2009.08.036.", "ArticleIdList": ["10.1016/j.bmc.2009.08.036", "19729316"]}, {"Citation": "Zhang T., Wu Z., Du J., Hu Y., Liu L., Yang F., Jin Q. Anti-Japanese-encephalitis-viral effects of kaempferol and daidzin and their RNA-binding characteristics. PLoS ONE. 2012;7:e30259. doi: 10.1371/journal.pone.0030259.", "ArticleIdList": ["10.1371/journal.pone.0030259", "PMC3262791", "22276167"]}, {"Citation": "Owis A.I., El-Hawary M.S., Dalia E.L., Amir Omar M.A., Abdelmohsen U.R., Kamel M.S. Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease. RSC Adv. 1957;10:19570\u201319575. doi: 10.1039/D0RA03582C.", "ArticleIdList": ["10.1039/D0RA03582C", "PMC9054211", "35515460"]}, {"Citation": "Ieven M., Vlietinick A.J., Berghe D.V., Totte J., Dommisse R., Esmans E., Alderweireldt F. Plant antiviral agents. III. Isolation of alkaloids from Clivia miniata Regel (Amaryl-lidaceae) J. Nat. Prod. 1982;45:564\u2013573. doi: 10.1021/np50023a009.", "ArticleIdList": ["10.1021/np50023a009", "7153775"]}, {"Citation": "Li S.Y., Chen C., Zhang H.Q., Guo H.Y., Wang H., Wang L., Zhang X., Hua S.N., Yu J., Xiao P.G., et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir. Res. 2005;67:18\u201323. doi: 10.1016/j.antiviral.2005.02.007.", "ArticleIdList": ["10.1016/j.antiviral.2005.02.007", "PMC7114104", "15885816"]}, {"Citation": "Flamand L., Lautenschlager I., Krueger G., Ablashi D., editors. Human Herpesviruses HHV-6A, HHV-6B and HHV-7: Diagnosis and Clinical Management. Elsevier; Amsterdam, The Netherlands: 2014."}, {"Citation": "Ren G., Ding G., Zhang H., Wang H., Jin Z., Yang G., Han Y., Zhang X., Li G., Li W. Antiviral activity of sophoridine against enterovirus 71 in vitro. J. Ethnopharmacol. 2019;236:124\u2013128. doi: 10.1016/j.jep.2019.02.045.", "ArticleIdList": ["10.1016/j.jep.2019.02.045", "30853644"]}, {"Citation": "Zhang Y., Zhu H., Ye G., Huang C., Yang Y., Chen R., Yu Y., Cui X. Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats. Life Sci. 2006;78:1998\u20132005. doi: 10.1016/j.lfs.2005.09.034.", "ArticleIdList": ["10.1016/j.lfs.2005.09.034", "16309710"]}, {"Citation": "Bleasel M.D., Peterson G.M. Emetine, Ipecac, Ipecac, Alkaloids and analogues as potential antiviral agents for coronaviruses. Pharmaceuticals. 2020;13:51. doi: 10.3390/ph13030051.", "ArticleIdList": ["10.3390/ph13030051", "PMC7151655", "32245264"]}, {"Citation": "Amoros M., Fauconnier B., Girre R.L. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus. Antivir. Res. 1987;8:13\u201325. doi: 10.1016/0166-3542(87)90084-2.", "ArticleIdList": ["10.1016/0166-3542(87)90084-2", "2825589"]}, {"Citation": "Sim\u00f5es C.M., Amoros M., Girre L. Mechanism of antiviral activity of triterpenoid saponins. Phytother. Res. 1999;13:323\u2013328. doi: 10.1002/(SICI)1099-1573(199906)13:4<323::AID-PTR448>3.0.CO;2-C.", "ArticleIdList": ["10.1002/(SICI)1099-1573(199906)13:4<323::AID-PTR448>3.0.CO;2-C", "10404540"]}, {"Citation": "Pu X., Ren J., Ma X., Liu L., Yu S., Li X., Li H. Polyphylla saponin I has antiviral activity against influenza A virus. Int. J. Clin. Exp. Med. 2015;8:18963.", "ArticleIdList": ["PMC4694421", "26770521"]}, {"Citation": "Bahbah E.I., Negida A., Nabet M.S. Purposing saikosaponins for the treatment of COVID-19. Med. Hypotheses. 2020;140:109782. doi: 10.1016/j.mehy.2020.109782.", "ArticleIdList": ["10.1016/j.mehy.2020.109782", "PMC7179490", "32353743"]}, {"Citation": "Yan Y.M., Shen X., Cao Y.K., Zhang J.J., Wang Y., Cheng Y.X. Discovery of anti-2019-nCoV agents from Chinese patent drugs via docking screening. Hypothesis. 2020 doi: 10.20944/preprints202002.0254.v1.", "ArticleIdList": ["10.20944/preprints202002.0254.v1"]}, {"Citation": "Teponno R.B., Kusari S., Spiteller M. Recent advances in research on lignans and neolignans. Nat. Prod. Rep. 2016;33:1044\u20131092. doi: 10.1039/C6NP00021E.", "ArticleIdList": ["10.1039/C6NP00021E", "27157413"]}, {"Citation": "Huang R.L., Huang Y.L., Ou J.C., Chen C.C., Hsu F.L., Chang C. Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro. Phytother. Res. 2003;17:449\u2013453. doi: 10.1002/ptr.1167.", "ArticleIdList": ["10.1002/ptr.1167", "12748977"]}, {"Citation": "Liu S., Wei W., Shi K., Cao X., Zhou M., Liu Z. In vitro and in vivo anti-hepatitis B virus activities of the lignan niranthin isolated from Phyllanthus niruri L. J. Ethnopharmacol. 2014;155:1061\u20131067. doi: 10.1016/j.jep.2014.05.064.", "ArticleIdList": ["10.1016/j.jep.2014.05.064", "25009077"]}, {"Citation": "Soto-Acosta R., Bautista-Carbajal P., Syed G.H., Siddiqui A., DelAngel R.M. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. Antivir. Res. 2014;109:132\u2013140. doi: 10.1016/j.antiviral.2014.07.002.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.002", "25017471"]}, {"Citation": "Syed G.H., Siddiqui A. Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. Hepatology. 2011;54:1936\u20131946. doi: 10.1002/hep.24619.", "ArticleIdList": ["10.1002/hep.24619", "PMC3236615", "21858850"]}, {"Citation": "Merino-Ramos T., de Oya N.J., Saiz J.C., Mart\u00edn-Acebes M.A. Antiviral activity of nordihydroguaiaretic acid and its derivative tetra-O-methyl nordihydroguaiaretic acid against West Nile virus and Zika virus. Antimicrob. Agents Chemother. 2017;61:e00376-17. doi: 10.1128/AAC.00376-17.", "ArticleIdList": ["10.1128/AAC.00376-17", "PMC5527643", "28507114"]}, {"Citation": "Wang S., Le T.Q., Kurihara N., Chida J., Cisse Y., Yano M., Kido H. Influenza virus\u2014cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 2010;202:991\u20131001. doi: 10.1086/656044.", "ArticleIdList": ["10.1086/656044", "PMC7537608", "20731583"]}, {"Citation": "Oyegunwa A.O., Sikes M.L., Wilson J., Scholle F., Laster S.M. Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-\u03baB-dependent transcription of TNF-\u03b1and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA. J. Inflamm. 2010;7:59. doi: 10.1186/1476-9255-7-59.", "ArticleIdList": ["10.1186/1476-9255-7-59", "PMC3002343", "21138578"]}, {"Citation": "Pollara J.J., Laster S.M., Petty I.T. Inhibition of poxvirus growth by Terameprocol, a methylated derivative of nordihydroguaiaretic acid. Antivir. Res. 2010;88:287\u2013295. doi: 10.1016/j.antiviral.2010.09.017.", "ArticleIdList": ["10.1016/j.antiviral.2010.09.017", "20888364"]}, {"Citation": "Chen H., Teng L., Li J.N., Park R., Mold D.E., Gnabre J., Hwu J.R., Tseng W.N., Huang R.C. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J. Med. Chem. 1998;41:3001\u20133007. doi: 10.1021/jm980182w.", "ArticleIdList": ["10.1021/jm980182w", "9685239"]}, {"Citation": "Gnabre J.N., Brady J.N., Clanton D.J., Ito Y., Dittmer J., Bates R.B., Huang R.C. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc. Natl. Acad. Sci. USA. 1995;92:11239\u201311243. doi: 10.1073/pnas.92.24.11239.", "ArticleIdList": ["10.1073/pnas.92.24.11239", "PMC40607", "7479972"]}, {"Citation": "Khanna N., Dalby R., Tan M., Arnold S., Stern J., Frazer N. Phase I/II clinical safety studies of terameprocol vaginal ointment. Gynecol. Oncol. 2007;107:554\u2013562. doi: 10.1016/j.ygyno.2007.08.074.", "ArticleIdList": ["10.1016/j.ygyno.2007.08.074", "17905420"]}, {"Citation": "Gao Y., Dong X., Kang T.G. Activity of in vitro anti-influenza virus of arctigenin. Chin. Tradit. Herb. Drugs. 2002;33:724\u2013725."}, {"Citation": "Fu L., Xu P., Liu N., Yang Z., Zhang F., Hu Y. Antiviral effect of arctigenin compound on influenza virus. Tradit. Chin. Drug Res. Clin. Pharmacol. 2008;4"}, {"Citation": "Hayashi K., Narutaki K., Nagaoka Y., Hayashi T., Uesato S. Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol. Pharm. Bull. 2010;33:1199\u20131205. doi: 10.1248/bpb.33.1199.", "ArticleIdList": ["10.1248/bpb.33.1199", "20606313"]}, {"Citation": "Schr\u00f6der H.C., Merz H., Steffen R., M\u00fcller W.E., Sarin P.S., Trumm S., Schulz J., Eich E. Differential in vitro anti-HIV activity of natural lignans. Z. F\u00fcr Nat. 1990;45:1215\u20131221. doi: 10.1515/znc-1990-11-1222.", "ArticleIdList": ["10.1515/znc-1990-11-1222", "1965681"]}, {"Citation": "Eich E., Pertz H., Kaloga M., Schulz J., Fesen M.R., Mazumder A., Pommier Y. -Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 1996;39:86\u201395. doi: 10.1021/jm950387u.", "ArticleIdList": ["10.1021/jm950387u", "8568830"]}, {"Citation": "Kuo Y.C., Kuo Y.H., Lin Y.L., Tsai W.J. Yatein from Chamaecyparis obtusa suppresses herpes simplex virus type 1 replication in HeLa cells by interruption the immediate-early gene expression. Antivir. Res. 2006;70:112\u2013120. doi: 10.1016/j.antiviral.2006.01.011.", "ArticleIdList": ["10.1016/j.antiviral.2006.01.011", "16540181"]}, {"Citation": "Wang Y., Wang X., Xiong Y., Kaushik A.C., Muhammad J., Khan A., Dai H., Wei D.Q. New strategy for identifying potential natural HIV-1 non-nucleoside reverse transcriptase inhibitors against drug-resistance: An in silico study. J. Biomol. Struct. Dyn. 2019;30:1\u20135. doi: 10.1080/07391102.2019.1656673.", "ArticleIdList": ["10.1080/07391102.2019.1656673", "31422767"]}, {"Citation": "Chen H., Liu P., Zhang T., Gao Y., Zhang Y., Shen X., Li X., Shen W. Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells. Oncol. Rep. 2018;39:921\u2013928. doi: 10.3892/or.2018.6191.", "ArticleIdList": ["10.3892/or.2018.6191", "PMC5802041", "29328465"]}, {"Citation": "Nesmelova E.F., Razakova D.M., Akhmedzhanova V.I., Bessonova I.A. Diphyllin from Haplophyllum alberti-regelii, H. bucharicum, and H. perforatum. Chem. Nat. Compd. 1983;19:608. doi: 10.1007/BF00576100.", "ArticleIdList": ["10.1007/BF00576100"]}, {"Citation": "S\u00f8rensen M.G., Henriksen K., Neutzsky-Wulff A.V., Dziegiel M., Karsdal M.A. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption. J. Bone Min. Res. 2007;22:1640\u20131648. doi: 10.1359/jbmr.070613.", "ArticleIdList": ["10.1359/jbmr.070613", "17576165"]}, {"Citation": "Martinez-Lopez A., Persaud M., Chavez M.P., Zhang H., Rong L., Liu S., Wang T.T., Sarafianos S.G., Diaz-Griffero F. Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus. EBioMedicine. 2019;47:269\u2013283. doi: 10.1016/j.ebiom.2019.08.060.", "ArticleIdList": ["10.1016/j.ebiom.2019.08.060", "PMC6796538", "31501074"]}, {"Citation": "Chen H.W., Cheng J.X., Liu M.T., King K., Peng J.Y., Zhang X.Q., Wang C.H., Shresta S., Schooley R.T., Liu Y.T. Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses. Antivir. Res. 2013;99:371\u2013382. doi: 10.1016/j.antiviral.2013.06.014.", "ArticleIdList": ["10.1016/j.antiviral.2013.06.014", "PMC3787953", "23820269"]}, {"Citation": "Susplugas S., Hung N.V., Bignon J., Thoison O., Kruczynski A., S\u00e9venet T., Gu\u00e9ritte F. Cytotoxic arylnaphthalene lignans from a Vietnamese acanthaceae, Justicia p atentiflora. J. Nat. Prod. 2005;68:734\u2013738. doi: 10.1021/np050028u.", "ArticleIdList": ["10.1021/np050028u", "15921419"]}, {"Citation": "Zhang H.J., Rumschlag-Booms E., Guan Y.F., Liu K.L., Wang D.Y., Li W.F., Cuong N.M., Soejarto D.D., Fong H.H., Rong L. Anti-HIV diphyllin glycosides from Justicia gendarussa. Phytochemistry. 2017;136:94\u2013100. doi: 10.1016/j.phytochem.2017.01.005.", "ArticleIdList": ["10.1016/j.phytochem.2017.01.005", "28110956"]}, {"Citation": "Yang Z., Wang Y., Zheng Z., Zhao S., Zhao J.I., Lin Q., Li C., Zhu Q., Zhong N. Antiviral activity of Isatis indigotica root-derived clemastanin B against human and avian influenza A and B viruses in vitro. Int. J. Mol. Med. 2013;31:867\u2013873. doi: 10.3892/ijmm.2013.1274.", "ArticleIdList": ["10.3892/ijmm.2013.1274", "23403777"]}, {"Citation": "Liu G.T. Bicyclol: A novel drug for treating chronic viral hepatitis B and C.  [(accessed on 12 July 2020)];Med. Chem. 2009 5:29\u201343. doi: 10.2174/157340609787049316. Available online:  https://www.ingentaconnect.com/content/ben/mc/2009/00000005/00000001/art00005.", "ArticleIdList": ["10.2174/157340609787049316", "19149648"]}, {"Citation": "Zhang J.T. New drugs derived from medicinal plants. Therapie. 2002;57:137\u2013150.", "ArticleIdList": ["12185962"]}, {"Citation": "Ruan B., Wang J.W., Bai X.L. Comparison of bicyclol therapy for patients with genotype B and C of hepatitis B virus. Zhonghua shi yan he lin chuang bing du xue za zhi= Zhonghua shiyan he linchuang bingduxue zazhi = Chin. J. Exp. Clin. Virol. 2007;21:366\u2013368.", "ArticleIdList": ["18322605"]}, {"Citation": "Liu C.H., Jassey A., Hsu H.Y., Lin L.T. Antiviral activities of silymarin and derivatives. Molecules. 2019;24:1552. doi: 10.3390/molecules24081552.", "ArticleIdList": ["10.3390/molecules24081552", "PMC6514695", "31010179"]}, {"Citation": "Song J.H., Choi H.J. Silymarin efficacy against influenza A virus replication. Phytomedicine. 2011;18:832\u2013835. doi: 10.1016/j.phymed.2011.01.026.", "ArticleIdList": ["10.1016/j.phymed.2011.01.026", "21377857"]}, {"Citation": "Cui Q., Du R., Liu M., Rong L. Lignans and their derivatives from plants as antivirals. Molecules. 2020;25:183. doi: 10.3390/molecules25010183.", "ArticleIdList": ["10.3390/molecules25010183", "PMC6982783", "31906391"]}, {"Citation": "Wen C.C., Kuo Y.H., Jan J.T., Liang P.H., Wang S.Y., Liu H.G., Lee C.K., Chang S.T., Kuo C.J., Lee S.S., et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 2007;50:4087\u20134095. doi: 10.1021/jm070295s.", "ArticleIdList": ["10.1021/jm070295s", "17663539"]}, {"Citation": "Vilhelmova-Ilieva N., Galabov A.S., Mileva M. Tannins as antiviral agents. Tannins-structural properties, biological properties and current knowledge. Alfredo Aires. 2019 doi: 10.5772/intechopen.86490.", "ArticleIdList": ["10.5772/intechopen.86490"]}, {"Citation": "Yang C.M., Cheng H.Y., Lin T.C., Chiang L.C., Lin C.C. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-\u03b2-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J. Ethnopharmacol. 2007;110:555\u2013558. doi: 10.1016/j.jep.2006.09.039.", "ArticleIdList": ["10.1016/j.jep.2006.09.039", "17113739"]}, {"Citation": "Notka F., Meier G., Wagner R. Concerted inhibitory activities of on HIV replication In vitro and ex vivo. Antivir. Res. 2004;64:93\u2013102. doi: 10.1016/j.antiviral.2004.06.010.", "ArticleIdList": ["10.1016/j.antiviral.2004.06.010", "15498604"]}, {"Citation": "Lin L.T., Chen T.Y., Chung C.Y., Noyce R.S., Grindley T.B., McCormick C., Lin T.C., Wang G.H., Lin C.C., Richardson C.D. Hydrolyzable tannins (chebulagic acid and punicalagin) target viral glycoprotein-glycosaminoglycan interactions to inhibit herpes simplex virus 1 entry and cell-to-cell spread. J. Virol. 2011;85:4386\u20134398. doi: 10.1128/JVI.01492-10.", "ArticleIdList": ["10.1128/JVI.01492-10", "PMC3126266", "21307190"]}, {"Citation": "Vilhelmova N., Jacquet R., Quideau S., Stoyanova A., Galabov A.S. Three-dimensional analysis of combination effect of ellagitannins and acyclovir on herpes simplex virus types 1 and 2. Antivir. Res. 2011;89:174\u2013181. doi: 10.1016/j.antiviral.2010.11.014.", "ArticleIdList": ["10.1016/j.antiviral.2010.11.014", "21134403"]}, {"Citation": "Vilhelmova-Ilieva N., Jacquet R., Quideau S., Galabov A.S. Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2. Antivir. Res. 2014;110:104\u2013114. doi: 10.1016/j.antiviral.2014.07.017.", "ArticleIdList": ["10.1016/j.antiviral.2014.07.017", "25111906"]}, {"Citation": "Vilhelmova-Ilieva N., Sirakov I., Jacquet R., Deffieux D., Quideau S., Galabov A.S. Antiviral activities of ellagitannins against bovine herpesvirus 1, suid alphaherpesvirus 1 and caprine herpesvirus 1. J. Vet. Med. Anim. Health. 2020;12:139\u2013143. doi: 10.5897/JVMAH2020.0857.", "ArticleIdList": ["10.5897/JVMAH2020.0857"]}, {"Citation": "Vilhelmova-Ilieva N., Deffieux D., Quideau S. Castalagin: Some aspects of the mode of anti-herpes virus activity. Ann. Antivir. Antiretrovir. 2018;2:004\u2013007. doi: 10.17352/aaa.000004.", "ArticleIdList": ["10.17352/aaa.000004"]}, {"Citation": "Wahyuni T.S., Azmi D.Z., Permanasari A., Adianti M., Lydia T., Widiandani T., Aoki U.C., Widyawaruyanti A., Fuad A., Hak H. Anti-viral activity of Phyllanthus niruri against hepatitis c virus. Malays. Appl. Biol. 2019;48:105\u2013111."}, {"Citation": "Dhama K., Karthik K., Khandia R., Chakraborty S., Munjal A., Latheef S.K., Kumar D., Ramakrishnan M.A., Malik Y.S., Singh R., et al. Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus. Front. Immunol. 2018;9:1803. doi: 10.3389/fimmu.2018.01803.", "ArticleIdList": ["10.3389/fimmu.2018.01803", "PMC6095993", "30147687"]}, {"Citation": "Munjal A., Khandia R., Dhama K., Sachan S., Karthik K., Tiwari R., Malik Y.S., Kumar D., Singh R.K., Iqbal H.M.N., et al. Advances in developing therapies to combat Zika virus: Current knowledge and future perspectives. Front. Microbiol. 2017;8:1469. doi: 10.3389/fmicb.2017.01469.", "ArticleIdList": ["10.3389/fmicb.2017.01469", "PMC5541032", "28824594"]}, {"Citation": "Singh R.K., Dhama K., Chakraborty S., Tiwari R., Natesan S., Khandia R., Munjal A., Vora K.S., Latheef S.K., Karthik K., et al. Nipah virus: Epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies\u2014A comprehensive review. Vet. Q. 2019;39:26\u201355. doi: 10.1080/01652176.2019.1580827.", "ArticleIdList": ["10.1080/01652176.2019.1580827", "PMC6830995", "31006350"]}, {"Citation": "Chen L., Hu C., Hood M., Zhang X., Zhang L., Kan J., Du J. A novel combination of vitamin C, curcumin and glycyrrhizic acid potentially regulates immune and inflammatory response associated with coronavirus infections: A perspective from system biology analysis. Nutrients. 2020;12:1193. doi: 10.3390/nu12041193.", "ArticleIdList": ["10.3390/nu12041193", "PMC7230237", "32344708"]}, {"Citation": "Dhama K., Sharun K., Tiwari R., Dadar M., Malik Y.S., Singh K.P., Chaicumpa W. COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum. Vaccin Immunother. 2020;16:1232\u20131238. doi: 10.1080/21645515.2020.1735227.", "ArticleIdList": ["10.1080/21645515.2020.1735227", "PMC7103671", "32186952"]}, {"Citation": "Gangal N., Nagle V., Pawar Y., Dasgupta S. Reconsidering traditional medicinal plants to combat COVID-19. AIJR 2020.  [(accessed on 24 August 2020)]; Available online:  https://preprints.aijr.org/index.php/ap/preprint/view/34."}, {"Citation": "Malik Y.S., Kumar N., Sircar S., Kaushik R., Bhat S., Dhama K., Gupta P., Goyal K., Singh M.P., Ghoshal U., et al. Coronavirus disease pandemic (COVID-19): Challenges and a global perspective. Pathogens. 2020;9:E519. doi: 10.3390/pathogens9070519.", "ArticleIdList": ["10.3390/pathogens9070519", "PMC7400054", "32605194"]}, {"Citation": "Rastogi S., Pandey D.N., Singh R.H. COVID-19 Pandemic: A pragmatic plan for Ayurveda intervention. J. Ayurveda Integr. Med. 2020 doi: 10.1016/j.jaim.2020.04.002.", "ArticleIdList": ["10.1016/j.jaim.2020.04.002", "PMC7177084", "32382220"]}, {"Citation": "Vellingiri B., Jayaramayya K., Iyer M., Narayanasamy A., Govindasamy V., Giridharan B., Ganesan S., Venugopal A., Venkatesan D., Ganesan H., et al. COVID-19: A promising cure for the global panic. Sci. Total Environ. 2020;725:138277. doi: 10.1016/j.scitotenv.2020.138277.", "ArticleIdList": ["10.1016/j.scitotenv.2020.138277", "PMC7128376", "32278175"]}, {"Citation": "Yang Y., Islam M.S., Wang J., Li Y., Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. Int J. Biol. Sci. 2020;16:1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Yatoo M.I., Hamid Z., Parray O.R., Wani A.H., Ul Haq A., Saxena A., Patel S.K., Pathak M., Tiwari R., Malik Y.S., et al. COVID-19\u2014Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Hum. Vaccin Immunother. 2020:1\u201314. doi: 10.1080/21645515.2020.1788310.", "ArticleIdList": ["10.1080/21645515.2020.1788310", "PMC8641591", "32703064"]}, {"Citation": "Dhama K., Chakraborty S., Tiwari R., Verma A.K., Saminathan M., Amarpal Y.M., Nikousefat Z., Javdani M., Khan R.U. A concept paper on novel technologies boosting production and safeguarding health of humans and animals. Res. Opin. Anim. Vet. Sci. 2014;4:353\u2013370."}, {"Citation": "Abd El-Hack M.E., Alagawany M., Farag M.R., Arif M., Emam M., Dhama K., Sarwar M., Sayab M. Nutritional and pharmaceutical applications of nanotechnology: Trends and advances. Int. J. Pharm. 2017;13:340\u2013350."}, {"Citation": "Prasad M., Lambe U.P., Brar B., Shah I., Manimegalai J., Ranjan K., Rao R., Kumar S., Mahant S., Khurana S.K., et al. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed. Pharm. 2018;97:1521\u20131537. doi: 10.1016/j.biopha.2017.11.026.", "ArticleIdList": ["10.1016/j.biopha.2017.11.026", "29793315"]}, {"Citation": "Borkotoky S., Banerjee M. A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem) J. Biomol. Struct. Dyn. 2020:1\u20137. doi: 10.1080/07391102.2020.1774419.", "ArticleIdList": ["10.1080/07391102.2020.1774419", "PMC7311162", "32462988"]}, {"Citation": "Manoharan Y., Haridas V., Vasanthakumar K.C., Muthu S., Thavoorullah F.F., Shetty P. Curcumin: A wonder drug as a preventive measure for COVID19 management. Indian J. Clin. Biochem. 2020;35:373\u2013375. doi: 10.1007/s12291-020-00902-9.", "ArticleIdList": ["10.1007/s12291-020-00902-9", "PMC7299138", "32641876"]}, {"Citation": "Zahedipour F., Hosseini S.A., Sathyapalan T., Majeed M., Jamialahmadi T., Al-Rasadi K., Banach M., Sahebkar A. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother. Res. 2020;34:2911\u20132920. doi: 10.1002/ptr.6738.", "ArticleIdList": ["10.1002/ptr.6738", "PMC7276879", "32430996"]}, {"Citation": "Straughn A.R., Kakar S.S. Withaferin A: A potential therapeutic agent against COVID-19 infection. J. Ovarian Res. 2020;13:1\u20135. doi: 10.1186/s13048-020-00684-x.", "ArticleIdList": ["10.1186/s13048-020-00684-x", "PMC7369003", "32684166"]}, {"Citation": "Pandey P., Khan F., Kumar A., Srivastava A. Screening of potent inhibitors against 2019 novel coronavirus (Covid-19) from Allium sativum and Allium cepa: An in silico approach. Biointerface Res. Appl. Chem. 2020;11:7981\u20137993. doi: 10.33263/BRIAC111.79817993.", "ArticleIdList": ["10.33263/BRIAC111.79817993"]}, {"Citation": "Meireles D., Gomes J., Lopes L., Hinzmann M., Machado J. A review of properties, nutritional and pharmaceutical applications of Moringa oleifera: Integrative approach on conventional and traditional Asian medicine. Adv. Tradit. Med. 2020;17:1\u201321. doi: 10.1007/s13596-020-00468-0.", "ArticleIdList": ["10.1007/s13596-020-00468-0"]}, {"Citation": "Russo M., Moccia S., Spagnuolo C., Tedesco I., Russo G.L. Roles of flavonoids against coronavirus infection. Chem. Biol. Interact. 2020:109211. doi: 10.1016/j.cbi.2020.109211.", "ArticleIdList": ["10.1016/j.cbi.2020.109211", "PMC7385538", "32735799"]}, {"Citation": "Su H., Yao S., Zhao W., Li M., Liu J., Shang W., Xie H., Ke C., Gao M., Yu K., et al. Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro. bioRxiv. 2020 doi: 10.1101/2020.04.13.038687.", "ArticleIdList": ["10.1101/2020.04.13.038687"]}, {"Citation": "Awad R., Arnason J.T., Trudeau V., Bergeron C., Budzinski J.W., Foster B.C., Merali Z. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): A medicinal plant with anxiolytic properties. Phytomedicine. 2003;10:640\u2013649. doi: 10.1078/0944-7113-00374.", "ArticleIdList": ["10.1078/0944-7113-00374", "14692724"]}, {"Citation": "Basha S.H. Corona virus drugs\u2013a brief overview of past, present and future. J. Peer Sci. 2020;2:e1000013. doi: 10.5281/zenodo.3747641.", "ArticleIdList": ["10.5281/zenodo.3747641"]}, {"Citation": "Salehi B., Kumar N.V., \u015eener B., Sharifi-Rad M., K\u0131l\u0131\u00e7 M., Mahady G.B., Vlaisavljevic S., Iriti M., Kobarfard F., Setzer W.N., et al. Medicinal plants used in the treatment of human immunodeficiency virus. Int. J. Mol. Sci. 2018;19:1459. doi: 10.3390/ijms19051459.", "ArticleIdList": ["10.3390/ijms19051459", "PMC5983620", "29757986"]}, {"Citation": "Bosch-Barrera J., Martin-Castillo B., Bux\u00f3 M., Brunet J., Encinar J.A., Menendez J.A. Silibinin and SARS-CoV-2: Dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 patients. J. Clin. Med. 2020;9:1770. doi: 10.3390/jcm9061770.", "ArticleIdList": ["10.3390/jcm9061770", "PMC7356916", "32517353"]}, {"Citation": "Orhan I.E., Deniz F.S. Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Nat. Prod. Bioprospecting. 2020;10:171\u2013186. doi: 10.1007/s13659-020-00250-4.", "ArticleIdList": ["10.1007/s13659-020-00250-4", "PMC7289229", "32529545"]}, {"Citation": "Laskar M.A., Choudhury M.D. Search for therapeutics against COVID 19 targeting SARS-CoV-2 papain-like protease: An in silico study. ChemRxiv. 2020 doi: 10.21203/rs.3.rs-33294/v1.", "ArticleIdList": ["10.21203/rs.3.rs-33294/v1"]}, {"Citation": "Lou C., Zhu Z., Zhao Y., Zhu R., Zhao H. Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2/-9 and heparanase in MDA-MB-231 cells. Oncol. Rep. 2017;37:179\u2013184. doi: 10.3892/or.2016.5269.", "ArticleIdList": ["10.3892/or.2016.5269", "27878294"]}, {"Citation": "Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., Deng Y., Wang H., Ye F., Cen S., et al. High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses. J. Virol. 2019;93:e00023. doi: 10.1128/JVI.00023-19.", "ArticleIdList": ["10.1128/JVI.00023-19", "PMC6613765", "30918074"]}, {"Citation": "Zhang Y.N., Zhang Q.Y., Li X.D., Xiong J., Xiao S.Q., Wang Z., Zhang Z.R., Deng C.L., Yang X.L., Wei H.P., et al. Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg. Microbes Infect. 2020;9:1170\u20131173. doi: 10.1080/22221751.2020.1772676.", "ArticleIdList": ["10.1080/22221751.2020.1772676", "PMC7448857", "32432977"]}, {"Citation": "Gurung A.B., Ali M.A., Lee J., Farah M.A., Al-Anazi K.M. Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci. 2020;255:117831. doi: 10.1016/j.lfs.2020.117831.", "ArticleIdList": ["10.1016/j.lfs.2020.117831", "PMC7243810", "32450166"]}, {"Citation": "Ma G., Yasunaga J.I., Ohshima K., Matsumoto T., Matsuoka M. Pentosan polysulfate demonstrates anti-human T-cell leukemia virus type 1 activities in vitro and in vivo. J. Virol. 2019;93:e00413-19. doi: 10.1128/JVI.00413-19.", "ArticleIdList": ["10.1128/JVI.00413-19", "PMC6675881", "31167921"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "17"}, {"Year": "2021", "Month": "3", "Day": "17"}, {"Year": "2021", "Month": "3", "Day": "18"}, {"Year": "2021", "Month": "4", "Day": "3", "Hour": "1", "Minute": "34"}, {"Year": "2021", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["33809963", "PMC8004635", "10.3390/molecules26061775", "molecules26061775"]}}], "PubmedBookArticle": []}